Medical News

RSS

Rimonabant may prevent and treat obesity-related liver disease

A new study on the effect of the anti-obesity drug rimonabant on liver function in obese rats found that it reduced markers of liver damage, decreased levels of pro-inflammatory proteins, and improved lipid profiles.

4 Jul 2007

Barr to market generic LAMISIL tablets

Barr Pharmaceuticals has announced that Gedeon Richter, Plc. has received final U.S. Food & Drug Administration (FDA) approval for its application to manufacture and market a generic version of Novartis Pharmaceutical Corporation's LAMISIL (terbinafine hydrochloride) Tablets, 250 mg. The approval follows the expiration of pediatric exclusivity for LAMISIL.

4 Jul 2007

Antidepressant warnings linked to decreased prescription rates among children

Regulatory warnings regarding the risk of suicidal thoughts and behaviors appear to be associated with reductions in the number of antidepressant medication prescriptions among children and adolescents covered by Tennessee's expanded Medicaid program, according to a report in the July issue of Archives of Pediatrics & Adolescent Medicine.

4 Jul 2007

IgG, an immune system antibody significantly higher in spinal fluid of blacks with MS

An antibody frequently used as a diagnostic marker for multiple sclerosis (MS) is present at greater levels in the cerebrospinal fluid of blacks with MS than Caucasians with the disease.

4 Jul 2007

30 percent of Americans report having some form of alcohol use disorder

About 30 percent of Americans report having some form of alcohol use disorder at some point in their lifetimes, including 17.8 percent with alcohol abuse and 12.5 percent with alcohol dependence, according to a report in the July issue of Archives of General Psychiatry, one of the JAMA/Archives journals.

4 Jul 2007

Smokeless tobacco, good or bad?

Should the health community promote smokeless tobacco (snus) as a harm reduction measure?

4 Jul 2007

Live donors have genuine concerns with insurance problems

According to a new review in American Journal of Transplantation, people who donate their kidney or part of their liver to help someone else may themselves encounter difficulty with life and health insurance, despite insurance companies saying otherwise.

4 Jul 2007

Study shows inaccuracies in cardiac PET-CT imaging

Current PET-CT scanners with standard commercial software designed to provide images of the heart are falsely indicating coronary artery disease in as many as 40 percent of patients, according to a study published today on the cover page of the Journal of Nuclear Medicine.

4 Jul 2007

Scientists measure distraction

A scientific indicator of how easily distracted you are has been designed by a UCL (University College London) psychologist. It could be used as another assessment tool during the recruitment process and would have particular benefits in fields where employee distraction could lead to fatal errors.

4 Jul 2007

High cholesterol makes people more prone to tick disease human granulocytic anaplasmosis

People who have high cholesterol levels may be much more susceptible to a particular disease transmitted by the bites of ticks, a new study in mice suggests.

4 Jul 2007

Hearing loss and von Hippel-Lindau disease

Patients with the genetic disorder von Hippel-Lindau disease may suddenly experience hearing loss because of a tumor-associated hemorrhage in the inner ear, according to a study in the July 4 issue of JAMA.

4 Jul 2007

Antidepressants not linked to birth defects

Two research studies published in The New England Journal of Medicine found taking SSRIs (selective serotonin reuptake inhibitors), anti-depression drugs, during pregnancy did not significantly increase the overall risk for most birth defects.

4 Jul 2007

Lung cancer patients taking Tarceva who develop a rash fair better

The appearance of a rash in cancer patients treated with erlotinib (Tarceva) is strongly associated with longer survival, according to researchers from the drug's developer, OSI Pharmaceuticals, Inc.

4 Jul 2007

Stem cell procedure successfully treats amyloidosis patients

Researchers from the Stem Cell Transplant Program and the Amyloid Treatment and Research Program at Boston University Medical Center (BUMC) have found that tandem cycles of high-dose chemotherapy and blood stem cell transplantation can help treat patients with immunoglobulin-light chain (AL) Amyloidosis who did not respond to initial treatment with this method.

4 Jul 2007